Renew Biopharma
Manufacturing · 1-10 Employees
View Company Info for Free
Overview
Website
www.renewbiopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Renew Biopharma
Renew Biopharma specializes in synthetic biology to develop proprietary therapeutics aimed at pain management, neurodegenerative diseases, and traumatic brain injuries. The company utilizes engineered enzymes to create novel molecules that effectively cross the blood-brain barrier and target specific receptors related to neuroinflammation and chronic pain. With a strong foundation in biotechnology and a robust intellectual property portfolio, Renew Biopharma is committed to improving human health through innovative therapeutic solutions. Their mission focuses on harnessing microbial synthetic biology to produce powerful new therapeutics for neuroinflammatory diseases.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Renew Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Renew Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Renew Biopharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Renew Biopharma has new funding data
Check if Renew Biopharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Renew Biopharma
Check out if Renew Biopharma is spiking on competitors!
Product Launch: Get notified when Renew Biopharma launches new products
Earning: See what the market has to say on Renew Biopharma recently announced quarterly report
Recommended Actions
Find VP level buyers at Renew Biopharma
Find 3 more new buyers
Compare Similar Companies to Renew Biopharma
Compare insights from companies similar to Renew Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Renew Biopharma
<$5M
1-10
Private
-
2017
N/A
Company Profile Activity
Activity Insights
Renew Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Renew Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Renew Biopharma.
Renew Biopharma Tech Stack
A closer look at the technologies used by Renew Biopharma
Renew Biopharma News & Media
Renew Biopharma and Algae-C Announce License Agreement for Best-in-Class Engineered Enzymes
SAN DIEGO--(BUSINESS WIRE)-- #AlgaeC--Renew Biopharma (“Renew”) announced today that Algae-C Inc. (“Algae-C”) has licensed rights to employ Renew’s proprietary engineered enzymes for use toward biosynthesis of cannabinoids in microalgae. Renew’s portfolio of engineered enzymes are designed to support enhanced production of cannabinoids and cannabinoid derivatives. While Renew has employed these enzymes towards the company’s neurotherapeutic drug discovery program, these same enzymes can also supRenew Biopharma Announces New Executive Leadership to Drive its Drug Discovery Program
SAN DIEGO--(BUSINESS WIRE)-- #Cannabinoids--Renew Biopharma, a leader in drug discovery and development of novel cannabinoids for human therapeutics, announced the addition of Steve Orndorff, Ph.D., as Chief Operating Officer. Dr. Orndorff, is a seasoned business executive, scientist and serial entrepreneur, with more than 30 years of experience in drug discovery and development in various roles of management, business development, manufacturing and commercialization. He has been involved in theU.S. Patent Office Grants Renew Biopharma Pivotal Patent for Cannabinoid Biosynthesis
SAN DIEGO--(BUSINESS WIRE)-- #Cannabinoids--Renew Biopharma today announced that the United States Patent and Trademark Office (USPTO) has granted powerful patent claims on the landmark patent application (WO2019183152) relating to the rational-based engineering of a key enzyme that is most efficient for large-scale microbial cannabinoid biosynthesis (i.e. NphB). This key enzyme produces CBGA and CBG, the precursors to most cannabinoids (including THC and CBD). Renew is a pre-clinical startup drRenew Biopharma Announces Landmark Patent in Cannabinoid Biosynthesis; CEO to Speak Today at SynBioBeta
SAN FRANCISCO--(BUSINESS WIRE)-- #BeyondThePlant--Renew Biopharma, a pre-clinical startup drug company developing new, proprietary small molecules to improve human health — focused particularly on neurotherapeutics — today announced a new landmark patent covering the extensive enzyme engineering of the key step for the production of cannabinoids and cannabinoid derivatives using microbial biosynthesis. This key step is governed by the enzyme that produces CBGA, the precursor to most cannabinoids
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Renew Biopharma
Sign Up For FreeTo access detailed company insights
Renew Biopharma specializes in synthetic biology to develop proprietary therapeutics aimed at pain management, neurodegenerative diseases, and traumatic brain injuries. The company utilizes engineered enzymes to create novel molecules that effectively cross the blood-brain barrier and target specific receptors related to neuroinflammation and chron... Read More
